MetaCap

Co-Diagnostics (CODX) vs Vivos Therapeutics (VVOS)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Vivos Therapeutics is the larger company by market cap ($1.8 million vs $1.4 million), about 1.3 times the size. Vivos Therapeutics converts more of its revenue into profit, with a net margin of -121.4% versus -7533.6%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CODX-88.44%VVOS-64.24%
+17%-38%-93%
Oct 7, 20261 yearNov 20, 2026
CODX-88.44%VVOS-63.73%
+4%-44%-93%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CODX versus VVOS key metrics
MetricCODXVVOS
Share price$0.1295$0.054
Market cap$1.36M$1.83M
1-day change-21.32%-5.10%
EPS (TTM)$-21.71$-1.35
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$622.49K$17.44M
Revenue growth (YoY)-84.10%+16.05%
Net income (latest FY)$-46.90M$-21.17M
Gross margin64.28%60.44%
Operating margin-8058.83%-114.05%
Net margin-7533.62%-121.37%
52-week high$13.54$2.69
52-week low$0.1276$0.05
Distance from 52-week high-99.04%-97.99%
Analyst consensusnonenone
Avg. price target upside+2988.80%+3825.93%
Average volume2.03M14.44M
Shares outstanding10.51M33.82M
Employees115268
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Vivos Therapeutics is more profitable, keeping -121.4 cents of every revenue dollar as net income versus -7533.6 cents for Co-Diagnostics.
  • Vivos Therapeutics grew revenue faster in its latest fiscal year (+16.05% vs -84.10%).

About Co-Diagnostics

CODX stock →

Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally.

Health Care · Medical/Dental Instruments · 115 employees

About Vivos Therapeutics

VVOS stock →

Vivos Therapeutics, Inc. operates as a medical technology and healthcare services company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults.

Health Care · Medical/Dental Instruments · 268 employees

CODX vs VVOS FAQ

Which is bigger, Co-Diagnostics or Vivos Therapeutics?

Vivos Therapeutics (VVOS) is larger, with a market capitalization of $1.83M compared with $1.36M for Co-Diagnostics (CODX).

Are Co-Diagnostics and Vivos Therapeutics in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons